[
    [
        {
            "time": "",
            "original_text": "大摩：上调复星医药(2196.HK)目标价至61.3港元 评级“与大市同步”",
            "features": {
                "keywords": [
                    "复星医药",
                    "目标价",
                    "上调",
                    "61.3港元",
                    "与大市同步"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大摩：上调复星医药(2196.HK)目标价至61.3港元 评级“与大市同步”",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "大摩：予复星医药(02196)“与大市同步”评级 目标价升9.4%至61.3港元",
            "features": {
                "keywords": [
                    "复星医药",
                    "目标价",
                    "上升",
                    "9.4%",
                    "61.3港元",
                    "与大市同步"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大摩：予复星医药(02196)“与大市同步”评级 目标价升9.4%至61.3港元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]